FEDERATED HERMES, INC.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1056288
PITTSBURGH, PA
Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$21,191,989
-$10,879,404 QoQ
Shares Held
42,663
-40.6% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#253
of 1,735 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. VRTX ranks #32 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,191,989 | 42,663 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $32,071,393 | 71,822 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $35,208,389 | 77,661 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $73,067,881 | 186,569 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $86,350,545 | 193,959 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $82,532,361 | 170,233 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $76,140,501 | 189,075 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $89,266,988 | 191,939 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $99,200,836 | 211,642 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $88,582,586 | 211,915 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $83,559,334 | 205,361 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $67,050,876 | 192,819 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $55,407,524 | 157,448 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $53,454,459 | 169,659 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $43,612,131 | 151,022 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $45,281,159 | 156,390 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $49,705,219 | 176,391 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $62,671,421 | 240,148 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $58,651,645 | 267,084 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $45,464,313 | 250,644 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $34,693,262 | 172,064 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $58,176,951 | 270,729 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $78,066,645 | 330,315 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $98,304,980 | 361,256 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $105,828,154 | 364,535 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $94,908,022 | 398,857 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||